Results 121 to 130 of about 3,657 (192)

Synthesis and Evaluation of Nitroheterocyclic Aromatic Adamantanohydrazones with Trypanocidal Activity. Part III. [PDF]

ACS Infect Dis
Foscolos AS, Stavropoulou K, Santarém N, Cordeiro da Silva A, Taylor MC, Calogeropoulou T, Tsotinis A, Papanastasiou IP, Kelly JM, Wyllie S.   +9 more
europepmc   +1 more source

Whole-Genome Sequencing and Phenotypic Drug Susceptibility Testing of Bedaquilin, Delamanid, Pretomanid, and Linezolid in Drug-Resistant <i>Mycobacterium tuberculosis</i> from a Single Institute in South Korea. [PDF]

Pathogens
Choi HW, Kang YR, Son ES, Choi K, Cho M, Kim YJ, Lee SA, Lee JY, Kim JH, Kang SJ, Kee SJ, Lee JS, Lee HJ.   +12 more
europepmc   +1 more source

Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho. [PDF]

Emerg Infect Dis
Seung KJ, Asfaw M, Kunda M, Maama-Maime LB, Makaka J, Mofolo M, Mpinda S, Ndayizigiye M, Omar SV, Prasad P, Rupasinghe P, Yarbrough C, Oyewusi L.   +12 more
europepmc   +1 more source

Successful treatment of pre-extensively drug-resistant tuberculous meningoencephalomyelitis in pregnancy with a bedaquiline and delamanid-based regimen: a case report. [PDF]

BMC Infect Dis
Nie Q, Liu Y, Xiao F, Zhou Y, Fu T, Zheng L, Huang D, Tang Q, Liu T, Tao L.   +9 more
europepmc   +1 more source

Wild-type MIC distribution and evaluation of epidemiological cut-offs of second-line TB-drugs in susceptible and MDR-TB clinical isolates from Chennai, India. [PDF]

Front Microbiol
Dusthackeer A, Balasubramanian M, Rajadas SE, Nirmal CR, Elango P, Thiruvengadam K, Saadhali SA, Shanmugam S.   +7 more
europepmc   +1 more source

Preventing Multidrug-Resistant Tuberculosis: The Dawn of a New Era. [PDF]

Clin Infect Dis
Churchyard GJ, Swindells S, Gupta A, Shah NS, Hughes M, Kim S, Fox GJ, Harrington M, Chaisson RE, Hesseling AC.   +9 more
europepmc   +1 more source

Computational Identification of Active Drug Metabolites for Human Protein Targets. [PDF]

Mol Pharm
Larsson S, Mercado R, Winiwarter S, Miljković F.   +3 more
europepmc   +1 more source

A drug-resistant TB cluster in a refugee family with Mendelian susceptibility to mycobacterial disease (MSDM). [PDF]

IJTLD Open
Boktor HAZ, Monedero-Recuero I, Al Shatnawi A, Halaseh H, Nejm MA, Satyanarayana S, Wilson N, Dent R, Maaia I, Okkeh K.   +9 more
europepmc   +1 more source

<i>In vitro</i> exposure to clofazimine can select for delamanid and pretomanid resistance in <i>Mycobacterium tuberculosis</i>. [PDF]

Antimicrob Agents Chemother
Rupasinghe P, Ismail N, Mulders W, Warren RM, Joseph L, Ngcamu D, Gwala T, Omar SV, Vereecken J, de Jong BC, Rigouts L, Borroni E, Cirillo DM, Schön T, Miotto P, Köser CU.   +15 more
europepmc   +1 more source

Corrigendum to "Model-Informed Once-Daily Dosing Strategy for Bedaquiline and Delamanid in Children, Adolescents and Adults with Tuberculosis". [PDF]

Clin Pharmacol Ther
europepmc   +1 more source